News | Press Releases

---

March 23, 2018

Canon Medical Systems’ Premium Ultrasound Provides New and Unique Features for a Wide Range of Liver Analysis

Industry’s Most Comprehensive Liver Analysis Suite with Attenuation Imaging and Shear Wave Dispersion

TUSTIN, Calif., March 23, 2018 – A robust suite of quantitative tools to assess the spectrum of liver disease (including Steatosis, Inflammation and Cirrhosis) on Canon Medical Systems USA, Inc.’s premium Aplio^TM i800 ultrasound system received FDA clearance. The industry’s most comprehensive Liver Analysis Suite is available on the Aplio i800, and may be helpful in the assessment of liver diseases such as steatosis, Non-Alcoholic Fatty Liver Disease (NAFLD) and/or Non-Alcoholic Steatohepatitis (NASH), which are characterized by elevated levels of fat accumulation in the liver.

Canon Medical Systems’ Liver Analysis Suite equips clinicians with premium diagnostic imaging tools to facilitate the analysis of Fatty Liver Disease. In addition to Shear Wave Elastography imaging, the new suite adds Attenuation Imaging (ATI) and Shear Wave Dispersion (SWD), two exclusive features that allow health care providers to visualize and quantify tissue attenuation and dispersion slope, which is a property related to tissue viscosity, for a more comprehensive evaluation of the liver.

In addition to the Liver Analysis Suite, a wider range of transducers, available on the Aplio i-series platform, have also been granted FDA clearance. On top of the ultra-high frequency transducer (24 MHz), the Aplio i-series now includes a new 22 MHz hockey stick to visualize small and narrow areas such as fingers and joints or for interoperative procedures, as well as several new transducers for abdominal 3D, OB 4D, neonatal and vascular imaging.

“The incidence of both viral and fatty liver disease is growing rapidly*, and the impact of liver disease, at every stage, is highly significant in the United States,” said Dan Skyba, director, Ultrasound Business Unit, Canon Medical Systems USA, Inc. “Canon is committed to new, non-invasive imaging technologies that put innovative tools in the hands of clinicians so that they can assess liver diseases earlier which may help improve a patient’s quality of life.”

The premium Liver Analysis Suite on the Aplio i800 and the transducers on the Aplio i-series will be showcased at this year’s American Institute of Ultrasound in Medicine (AIUM) 2018 annual meeting in New York, March 24 – 28, 2018 (Booth #1600).

About Canon Medical Systems USA, Inc.

Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit Canon Medical Systems’ website at https://us.medical.canon.

About Canon Medical Systems Corporation

Canon Medical Systems Corporation develops and manufactures diagnostic imaging systems including CT, MRI, ultrasound, X-ray systems and clinical laboratory systems and provides them to around 140 countries and regions around the world, offering technology that provides faster diagnosis and early treatment. Under the slogan “Made for Life” (Made for Partnerships, Made for Patients, Made for You.), Canon Medical Systems is making positive contributions toward hospital management, and provides a range of patient-friendly healthcare systems and services, continuing its long tradition of contributing to healthcare.

###

* https://www.hepmag.com/article/liver-diseases-types-rise-among-middleaged-americans